Contribute Try STAT+ Today

A STAT Investigation

Most Read

IBM Watson main illo

A STAT Investigation By Casey Ross and Ike Swetlitz

IBM pitched its Watson supercomputer as a revolution in cancer care. It’s nowhere close

A STAT Investigation By Charles Piller

Failure to warn: Hundreds died while taking an arthritis drug, but nobody alerted patients

Sam Isaly

Exclusive By Damian Garde

Biotech hedge fund titan Sam Isaly harassed, demeaned women for years, former employees say

STAT + Boston Globe Investigation By David Armstrong and Evan Allen — Boston Globe

Behind the luxury: Turmoil and shoddy care inside five-star addiction treatment centers

A STAT Investigation By Charles Piller and Talia Bronshtein

Faced with public pressure, research institutions step up reporting of clinical trial results

Politics By Talia Bronshtein

Nerd’s notes: How we did the ClinicalTrials.gov data analysis

Sentinel

A STAT Investigation By Sheila Kaplan

Failure to warn: An early warning system for drug risks falls flat

A STAT Investigation By Ike Swetlitz and Casey Ross

Watch: A new advertising tack for hospitals: IBM’s Watson supercomputer is in the house

All Coverage

Ahoskie

A STAT Investigation By Casey Ross

From a small town in North Carolina to big-city hospitals, how software infuses racism into U.S. health care

Hydroxychloroquine at Rock Canyon Pharmacy

Politics By Lev Facher

FDA revokes emergency use ruling for hydroxychloroquine, the drug touted by Trump as a Covid-19 therapy

advertisement

Hospital cloud data illo

A STAT Investigation By Casey Ross and Erin Brodwin

Hospitals turn to big tech companies to store and analyze their data — leaving patients in the dark on privacy protections

Ketamine Clouds

A STAT Investigation By Megan Thielking

Ketamine gives hope to patients with severe depression. But some clinics stray from the science and hype its benefits